Ignite Creation Date:
2024-05-05 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00502060
Status:
COMPLETED
Last Update Posted:
2009-05-14
First Post:
2007-07-13
Brief Title:
Phase I Study of AZD2171 co-Administered With Fixed Multiple Oral Doses of ZD1839 in Patients With Advanced Cancer
Sponsor:
AstraZeneca
Organization:
AstraZeneca